DOCU vs NDRA · P/E 15, rev $2.98B vs P/E 0.0, $2.6M cap
DocuSign Inc (DOCU) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
NDRA does not have a complete income-statement cache yet.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the DOCU and NDRA stock pages for the full models.
Not investment advice.